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Inflammatory bowel disease (IBD) and its two major disorders, Crohn's Disease (CD) and Ulcerative Colitis (UC), are a significant problem across the world, affecting about one in 200 people in developed countries and having a rising incidence and prevalence in developing countries (Molodecky et al. 2012) . IBD is associated with many debilitating symptoms, including urgent diarrhoea, rectal bleeding, vomiting, anorexia and lethargy, which frequently lead to poor psychosocial well-being with extensive consequences (Neovius et al. 2013) . The financial burden of IBD for the healthcare system is considerable, with more than 2.2 billion US$/year in the USA alone (Everhart & Ruhl 2009 ). The development and progression of IBD is considered to be based on a complex combination of genetic influences and environmental factors (Ellinghaus et al. 2015) , where disturbed host-microbiome interactions likely play a significant part (Jostins et al. 2012) .
Several of these IBD-relevant factors and influences are also risk factors for periodontitis (Brandtzaeg 2001 , Kinane & Bartold 2007 , Indriolo et al. 2011 . In addition, studies have shown that the progression of disease in both IBD and periodontitis is characterized by immunoinflammatory processes and tissue destruction (Brandtzaeg 2001 , Kinane & Bartold 2007 . Finally, several other oral manifestations of IBD have been reported in the last decades, including oral soft-tissue lesions, cobblestoning, aphthous ulcers, lymphadenopathy and pyostomatitis (Dudeney 1969 , Chan et al. 1991 , Scheper & Brand 2002 , Harty et al. 2005 .
To this end, periodontitis has been associated with a number of systemic diseases and conditions including diabetes, metabolic disorder and obesity (Chaffee & Weston 2010 , Suvan et al. 2011 , Nibali et al. 2013 , Papageorgiou et al. 2015a ). However, to our knowledge the possible association between IBD and periodontitis has not yet been adequately assessed in an evidencebased manner. Such evidence could identify similarities between the two entities that aid in the elucidation of the underlying biological principles of IBD and its forms, as well as provide information about an increased global burden of care for periodontal disease (Petersen & Ogawa 2012) in IBD patients.
Objectives
The primary aim of this systematic review was to investigate whether the prevalence of periodontal disease is higher in patients with IBD compared to IBD-free patients, with the main research question being: "Do IBD patients have the same prevalence of periodontal disease as IBDfree patients?". The secondary aim was to assess whether IBD is associated with other parameters of oral health.
Methods Protocol and registration
The protocol for this systematic review was made a priori, agreed upon from all authors and registered in PROSPERO (CRD42015019436) . This systematic review is conducted according to the Cochrane Handbook (Higgins & Green 2011) and reported according to the PRISMA statement (Liberati et al. 2009 ) and its extension for abstracts (Beller et al. 2013 ).
Eligibility criteria
Inclusion and exclusion criteria were determined a priori (Appendix S1). Both randomized controlled studies (RCTs) and non-RCTs that assessed any of the pre-specified periodontal or oral health outcomes in patients with and without IBD were included.
Information sources and search
Electronic general, open access, regional and grey literature databases were systematically searched up January 2017 (Appendix S2). MESH terms and relative keywords were used accordingly for each electronic database. No limitations were applied regarding publication year and status or language. The reference lists of included articles and relevant reviews were manually searched.
Grey literature was searched through appropriate databases and registers. Authors were contacted when necessary for additional data or clarifications.
Study selection
A study was judged as eligible, when none of the exclusion and all of the inclusion criteria were fulfilled. After removal of duplicates, articles were screened on the basis of title, abstract and full-text. When the decision on the basis of title and abstract was inconclusive, the full-text article was acquired. Additional reports of the same trial/cohort were grouped together. When an identical study was published in more than one language, the most complete report was preferred, irrespective of language. Study selection was initially conducted by one author (SNP), who screened the titles and/or abstracts of retrieved studies. Subsequently, the full texts of potentially eligible studies (and from those abstracts which did not provide sufficient information to include/exclude) were screened by two authors independently (SNP and MH) . Differences between the two authors were settled by a third author (JD).
Data collection process and data items
Data extraction was performed independently by the same two review authors (SNP and MH) in a predefined and piloted collection form. Any disagreement was resolved by discussion with a third author (JD). Outcomes to be included were specified a priori at the protocol stage. All given post-treatment timepoints were to be included, but no such data existed.
Risk of bias in individual studies
The risk of bias of RCTs was to be assessed with the Cochrane Collaboration's tool (Higgins & Green 2011) , but no RCTs were identified. The risk of bias of non-RCTs was assessed with a modified version of the Downs & Black (1998) checklist.
Summary measures and synthesis of results
Data were summarized and considered suitable for pooling, if similar disease groups were reported (or could be formed) and the same outcomes were reported. In cases of inadequate reporting, the missing data were calculated or requested from the authors. Data reported as medians and interquartile ranges were converted to means and standard deviations. If studies reported data for CD and UC, but not for IBD collectively, data were pooled prior to the meta-analysis (Higgins & Green 2011) .
Mean differences (MD) for continuous outcomes and Odds Ratios (ORs) for binary outcomes, together with their corresponding 95% confidence intervals (CI) were calculated. A random-effects model as proposed by DerSimonian & Laird (1986) was chosen a priori as the primary method to estimate all pooled estimates, since clinical heterogeneity was expected (Papageorgiou 2014a) . The extent and impact of betweenstudy heterogeneity was assessed by inspecting the forest plots for the localization of heterogeneity, by calculating the s 2 and the I² statistic, respectively, and assessing the magnitude and direction of heterogeneity. The 95% CIs around I 2 were calculated according to the noncentral v 2 approximation of Q. In case of considerable unexplained heterogeneity (I 2 > 75%) attempts were made to achieve homogeneity and, if they failed, meta-analysis was omitted. For meta-analyses with ≥3 trials, 95% prediction intervals (PrI) (Higgins et al. 2009 ) were calculated to predict effects in a future clinical setting. These incorporate observed heterogeneity in the meta-analysis estimates and provide a range of possible results that could exist in a future clinical setting. All analyses were performed in Stata version 12 (StataCorp LP, College Station, TX, USA) with the macros metan, heterogi and metareg. All p values were two-sided with a set at 5%, except for the test of heterogeneity, where a was set at 10%. No adjustment in the significance level was adopted to control for increased Type I error, since the nature of meta-analysis is observational per se and aims to identify existing significant associations.
Risk of bias across studies & additional analyses
The overall quality of evidence (confidence in effect estimates) for each of the main outcomes was rated using the GRADE approach (Guyatt et al. 2011) . For this assessment, the risk of bias of each included trial was re-assessed separately at outcome level. The minimal clinical important (Sloan et al. 2006 ), large, and very large effects for continuous outcomes were defined arbitrarily according to often-used conventions as half, one and two standard deviations, respectively (and as 1.5, 2.5 and 4.3 for the odds ratio). The standard deviation for an outcome was averaged from the existing trials. The produced forest plots were augmented with contours denoting the magnitude of the observed effects. Finally, the optimal information size (i.e. required metaanalysis sample size) was calculated for each outcome independently for a = 5% and b = 20%.
Random-effects meta-regressions were conducted for the comparison of IBD compared to healthy patients according to the following characteristics of IBD patients (a) mean age, (b) gender (assessed through the male/female ratio), (c) smoking (percentage of patients smoking), (d) IBD activity (percentage of patients with active disease), and (e) medication use, when at least three studies were included. Small study effects and signs of publication bias were planned to be assessed, if at least ten studies contributed to the meta-analyses. Sensitivity analyses were planned to be conducted to check the results' robustness according to follow-up, error of the method, definition of periodontitis, design of included studies (Papageorgiou et al. 2014 , Papageorgiou et al. 2015b , and improvement of the GRADE assessment.
Results

Study selection
A total of 362 and four papers were identified through the electronic (Appendix S3) and manual searches, respectively ( Fig. 1 ). After removal of duplicates and initial screening, 43 papers were judged against the eligibility criteria, leaving a final number of 14 included papers ( Fig. 1 ; Appendix S3; Table 1 ). Six publications (Barros 2007 , 2013 , Silva 2008 , Figueredo et al. 2011 , referring to the same study and its follow-ups, were grouped, leaving a total of nine unique studies that were finally included.
Study characteristics
The characteristics of the included studies are shown in Table 1 . Nine case-control studies from different countries were included with a total of 744 IBD patients and 553 healthy individuals. Among the IBD patients described in the included studies 379 of them (56%) had CD and 300 (44%) had UC. In the studies that reported demographic characteristics, the male/female patient distribution was balanced in the IBD and healthy groups (45-51% in the IBD and 45-54% in the healthy group). Likewise, the mean age across studies was balanced between the IBD The risk of bias assessment for the included studies can be seen in Table 2 . Serious methodological inadequacies that could be associated with bias were found in four studies for at least one methodological domain. Most problematic domains were the use of periodontal status as a criterion for patient enrollment in the study and incomplete reporting of patient characteristics or statistical analyses.
Results of individual studies and data synthesis
The results of the individual studies that did not contribute to the metaanalyses can be found in Appendix S4. The performed meta-analyses comparing IBD patients with healthy patients overall, CD patients with healthy patients, and UC patients with healthy patients are shown in Tables 3 and 4 , Fig. 2 , and Appendices S5-S8. Compared to healthy patients, patients with IBD were significantly more likely to have periodontitis (Fig. 2) , had significantly higher % of sites with large clinical attachment loss (3-5 mm) higher mean pocket probing depth, higher periodontal treatment need, higher decayed missing filling teeth (DMFT) index, and more oral lesions. Patients with CD, likewise, were significantly more likely to have periodontitis, had significantly higher DMFT index, and significantly higher percentage of sites with pocket probing depth >3 mm (Appendix S7). Finally, patients with UC were significantly more likely to have periodontitis or oral lesions, had significantly fewer teeth (Appendix S5), greater DMFT index (Appendix S6), greater percentage of sites with clinical attachment loss >3 mm, and greater pocket probing depth (Appendix S8).
Risk of bias across studies
The risk of bias across studies (quality of evidence) according to the GRADE approach is summarized in Table 4 and Appendix S9. As far as the primary outcome of this review, prevalence of periodontitis, Including six studies (Barros 2007 , 2013 , Silva 2008 , Figueredo et al. 2011 .
is concerned, high quality evidence supported the association of IBD generally (or CD and UC separately) with increased risk of periodontitis. IBD was associated with a higher risk of periodontitis by 332 patients per 1000 compared to healthy patients. The numbers-needed-to-treat indicated that for every three or four patients screened, an additional patient with periodontitis would be identified, if these patients had IBD. The subtype of IBD (CD or UC) had also a distinct effect on oral health, with UC patients being more severely affected compared to CD patients (additional increase in risk by 42 per 1000 patients).
As far as the two secondary outcomes of number of teeth and DMFT index of patient were concerned, low quality evidence indicated that IBD was associated with fewer teeth per patient and higher DMFT index. The only reason for the low GRADE score was the fact that it was based on observational non-experimental studies that provided only a snapshot picture of the disease. Patients with IBD (either CD or UC) had an average of one tooth less (p = 0.090) and a greater DMFT index by 3.85 (p = 0.005). Likewise, to the prevalence of periodontitis, both the number of teeth and the DMFT index were more severely affected in UC patients than in CD patients compared to healthy patients (Appendices S7 and S8). This was also seen in an explorative post-hoc comparison between UC and CD patients, where UC patients had significantly fewer teeth, higher plaque index, and greater attachment loss (Appendix S10).
Additional analyses
Random-effect meta-regressions according to patient characteristics failed to identify any significant modifying effect on periodontitis, number of teeth, and DMFT index (Appendix S11). Reporting biases were planned in the initial protocol, but could not be performed due to the limited number of trials included in the meta-analyses.
Sensitivity analysis according to the definition of periodontal disease was conducted by including studies with widely accepted definition of periodontitis (Appendix S12). This indicated that the results of the Table 2 . Methodological inadequacies associated with risk of bias within the included studies Definitely yes (low risk of bias), ; Probably yes, ; Not possible (unclear), ; Probably no, ; Definitely no (high risk of bias), .
*
Including six studies (Barros 2007 , 2013 , Silva 2008 , Figueredo et al. 2011 meta-analyses were robust in all instances. Sensitivity analysis according to the diagnostic criteria used to diagnose IBD, CD and UC (Appendix S13) could not be performed. Further sensitivity analyses were planned, but could not be conducted, due to the number and nature of the included studies.
Discussion
Summary of evidence
In this systematic review, the effect of IBD on periodontal disease and oral health was systematically assessed from nine observational clinical studies of 1297 patients. According to the results of the meta-analyses, IBD was associated with a significantly increased risk of periodontitis compared to the control group, which was more pronounced in UC rather than in CD.
Inflammatory bowel disease patients were significantly more likely to have periodontitis, had a higher percentage of sites with increased CAL, and had significantly higher mean PPD (Table 3) . The included studies differed at the level of patient oral hygiene or the percentage of patients receiving anti-TNF therapy for IBD [6% (Barros 2007) or 40% (Vavricka et al. 2013) ], but this was not reflected into considerable heterogeneity. The association between periodontitis and IBD has been attributed to common predisposing factors, such as age and genetic predisposition, as well as environmental or lifestyle factors (Indriolo et al. 2011) . Smoking is strongly associated with both periodontitis (Hujoel et al. 2002) and IBD (Mahid et al. 2006 ), but has a distinct detrimental role for CD and a protective role for UC (Mahid et al. 2006) . Although factors like socio-economic status and smoking, can confound this relationship, and indeed smokers were more heavily affected than non-smokers (Appendix S4), adjusted ORs for confounders from included studies were consistent. Some studies have focused on the role of cytokines (McGee et al. 1998 , Yucel-Lindberg et al. 1999 or specific pathogenic bacteria on periodontal destruction (Stein et al. 2010) and their alterations in IBD. In fact, it may be more useful to study the mechanisms explaining how the two IBD diseases are associated with periodontitis. A combination of genetic predisposition, environmental factors and a dysbiotic microbiota with an excessive host response are main etiological factors for the initiation and progression of periodontitis and inflammatory bowel disease (Brandtzaeg 2001 , Indriolo et al. 2011 . The healthy gut microbiota is mainly composed of strict anaerobes and dominated by Bacteroidetes and Firmicutes. Howerever, in inflammatory bowel disease, the relative abundance of Firmicutes and the diversity of the intestinal microbiota is greatly reduced (Bull & Plummer 2014 , Forbes et al. 2016 ) The oral microbiota is almost as complex as that of the colon and dominated by Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Spirochaetes, and Fusobacteria (Wade 2013) . During the transition from periodontal health to periodontitis, the microbiota of periodontal pockets shifts from a predominantly Gram-positive aerobic to a predominantly Gram-negative anaerobic dominance (Khan et al. 2015) . Periodontitis-associated species include Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Aggregatibacter actinmycetemcomitans, and many others. However, Porphyromonas gingivalis, which has an impressive armamentarium of virulence factors, is considered a "keystone pathogen", as this bacterium can cause dysbiosis of the periodontal microbiota, which subsequently results in the destruction of the toothsupporting tissues (Wade 2013 , Khan et al. 2015 . Ulcerative Colitis patients, both smokers and non-smokers, had worse oral health than CD patients, which suggests that the response to dental plaque may be different between these groups. Indeed, UC and CD differ regarding their immunopathogenesis, which involves the T helper (Th) cell differentiation; CD is considered to be a Th1 disease while UC has characteristics of a Th2 disease (Bouma & Strober 2003) . However, a direct explorative comparison (Appendix S10) indicated that included UC patients had a significantly higher plaque index than CD patients, which might have confounded this effect. Although this was not the main scope of this systematic review, the cariological evaluation revealed that IBD had a higher DMFT index (three studies; Table 3 ; MD = 3.85; p < 0.05), DMF-S index (MD = 7.60; p > 0.05) (Gr€ ossnerSchreiber et al. 2006), more dentine caries (OR = 2.39; p < 0.05), higher Decayed index (MD = 1.57; p < 0.05) ( Slebioda et al. 2011) , and more oral lesions (OR = 7.90; p < 0.05) than non-IBD patients. This is in accordance with previous reports (Sundh & Hult en 1982 , Rooney 1984 ) and could be attributed to nutrional behavioural changes and alterations in salivary and microbiological conditions in the oral cavity (Gr€ ossner-Schreiber et al. 2006). CD patients have been reported to have an increased intake of refined carbohydrates compared to normal (Sch€ utz et al. 2003) and to prefer sugary to fatty foods, due to its digestability and the concurrently less gastrointestinal symptoms (J€ arnerot et al. 1983 ), Additionally, it has been shown that although CD patients have normal saliva flow rate and buffer capacity, the number of salivary mutans streptococci and lactobacilli is higher than normal (J€ arnerot et al. 1983) . The combination of these two findings might explain the increased caries experience of IBD patients, although other studies disagree with this (Halme et al. 1993 , Meurman et al. 1994 .
Additionally, intraoral manifestations, including oral lesions, hairy tongue, ulcers, linea alba and recurrent aphthous stomatitis were more evident both in the composite IBD group, and in the separate CD or UC groups, compared to non-IBD patients (Tables 3; Appendices S4 , S7, and S8), which could additionally hamper oral hygiene.
Strengths and limitations
The strengths of the present review include the pre-defined protocol and outcomes (with deviations from it noted separately in Appendix S14), Fig. 2 . Forest plot with the meta-analyses regarding the prevalence of periodontitis. IBD, inflammatory bowel disease; n, affected patients; N, sample; OR, odds ratio; CI, confidence interval; adj, adjusted estimates; PrI, predictive interval; CD, Crohn's disease; UC, ulcerative colitis. the extensive literature search, and the strict methodology implemented during every stage of it, according to existing evidence-based guidelines. As both university and hospital settings were included, no specific inclusion criteria were adopted and the included studies were observational of nature, the results could be broadly generalized to the average patient.
Nevertheless, only a limited number of studies was identified assessing certain outcomes and some of them had uneven samples of IBD and non-IBD patients. Heterogeneity could not be explained in some cases due to the limited number of studies, while publication bias diagnostics and sensitivity analyses could not be performed, which might pose a threat to the results' validity (Papageorgiou 2014b , Papageorgiou et al. 2015c ). Additionally, a large number of outcomes reported from included studies were included in the systematic review, but not in the meta-analyses, as only one study contributed to their analysis (Appendix S4). It is possible that some significant differences reported by them correspond to actual differences between IBD and non-IBD patients. These can be evaluated in a future update of this review, if additional studies are included. Moreover, although this was not possible to evaluate in this review due to the limited information provided, it would be interesting to know in which cases the diagnosis of perdiodontal disease preceeds IBD or the other way around. Finally, the biggest limitation of this study is that only cross-sectional studies were included, which provide a snapshot picture of the evidence and cannot support a causality between IBD and periodontitis or vice versa.
Conclusion
According to high quality evidence originating from cross-sectional studies, inflammatory bowel disease is significantly associated with increased risk of periodontal disease. Additionally, low quality evidence from cross-sectional studies indicates that patients with inflammatory bowel disease have significantly greater caries experience compared to healthy patients.
Although considerable indications of impaired oral health in inflammatory bowel disease were found from this systematic review, this was based on cross-sectional studies of observational nature, which provide a "snapshot-picture" of a possible underlying pathology. Well-designed prospective controlled longitudinal studies of patients with/without inflammatory bowel disease and periodontitis are direly needed, in order to evaluate the impact of inflammatory bowel disease on oral health and its interrelation with tissue response to periodontic treatment.
